| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 5.5, positive 5.5, negative 0) on 20251112. The forces of Valuation Sentiment (3.3), Sentiment towards Fundamentals (2.2), Price Level (2), Sector Price Trend (1.6), Option Speculation (1.5), Broad Market Trend (0.3), and Market Risk Prefrence (0) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (5.5). The extreme bullish overall sentiment (5.5) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | 1% | 1% | 152.81 | 126 | 1.4% | 0.55% | 3.5 | 1.6 | 2.2 | 2.2 |
| 2025-11-11 | 1% | 1.1% | 150.69 | 126 | 2.32% | 0.41% | 3.1 | 0.9 | 2.2 | 2.2 |
| 2025-11-10 | 1% | 1.4% | 147.28 | 93 | 0.79% | 0.07% | 2.9 | 0.6 | 2.1 | -1.9 |
| 2025-11-09 | 0% | 1.6% | 3.8 | 0.5 | 2.1 | 8 | ||||
| 2025-11-08 | 1% | 1.7% | 3.4 | 0.5 | 2.1 | 7 | ||||
| 2025-11-07 | 1% | 1.7% | 146.12 | 77 | 0.14% | 0% | 0.8 | 0.5 | 2.1 | -0.6 |
| 2025-11-06 | 2% | 1.9% | 145.92 | 76 | 0.19% | -0.07% | 0.4 | 0.3 | 1.8 | 2.4 |
| 2025-11-05 | 2% | 2% | 145.64 | 74 | 0.43% | 0% | 0.7 | 0.1 | 1.9 | 1.2 |
| 2025-11-04 | 3% | 1.9% | 145.01 | 65 | 0.42% | 0% | 0.6 | -0.1 | 1.9 | 4.4 |
| 2025-11-03 | 2% | 1.7% | 144.41 | 54 | 0.12% | 0% | 0.3 | -0.5 | 1.7 | 2.7 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (8) Inside This Startup's Solution To An $80 Billion Healthcare Problem Bold Cofounder and CEO Amanda Rees sits down with ForbesWomen editor Maggie McGrath to discuss her company's model aimed at improving the "healthspan" of aging adults. (https://www.forbes.com/) Wed. Nov 12, 2025 | |
| 2 (7) AbbVie Shares Rise To Intraday High After Key Trading Signal A key trading signal flashed for AbbVie shares at a price of $228.47, after which ABBV rose as much as 2.4% to an intraday high of $233.90. (https://www.benzinga.com/) Wed. Nov 12, 2025 | |
| 3 (4) Siemens to Hand €15 Billion Stake in MRI Maker to Investors Siemens AG will hand a 30% stake in Siemens Healthineers AG to its own shareholders, allowing it to reduce its exposure to the medical technology business and focus on software. (https://www.bloomberg.com/) Wed. Nov 12, 2025 | |
| 4 (-2) Senate Punts On Health Insurance Subsidies To End Shutdown In this week’s edition of InnovationRx, we look at BillionToOne’s IPO, China’s biotech power couple and Lilly’s eye drug deal. (https://www.forbes.com/) Wed. Nov 12, 2025 | |
| 5 (7) Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data Novo Nordisk released new data to underscore its pill's safety and effectiveness, while Trump is asked whether private plans could see lower GLP-1 costs. (https://www.cnbc.com/) Wed. Nov 12, 2025 | |
| 6 (8) Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study Alkermes' alixorexton met key goals in a phase 2 study for narcolepsy type 2, showing significant improvements in wakefulness and sleepiness scores. (https://www.benzinga.com/) Wed. Nov 12, 2025 | |
| 7 (2) Pfizer: Could AI unlock new value for drug makers? Pfizer (PFE) managed to outbid competitor Novo Nordisk (NVO) to acquire Metsera (MTSR) in a deal valued at up to $10 billion. Pfizer stock is down by nearly 3% from this time a year ago. Robinhood (HOOD) Chief Investment Officer Stephanie Guild and Yahoo Finance senior reporters Brooke DiPalma and Ines Ferré discuss Pfizer's position in the healthcare space (XLV) and whether artificial intelligence could unlock new growth prospects for the pharmaceutical industry. Tune in on Thursday, November 13, for Yahoo Finance's interview with Pfizer CEO Albert Bourla at Yahoo Finance Invest. To watch more expert insights and analysis on the latest market action, check out more Opening Bid. (https://finance.yahoo.com/) Wed. Nov 12, 2025 | |
| 8 (-2) Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share. (https://www.benzinga.com/) Wed. Nov 12, 2025 | |
| 9 (-5) DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price? DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock. (https://www.fool.com/) Wed. Nov 12, 2025 | |
| 10 (-5) Lilly Drops CVS Drug Plan for Workers After Novo Obesity Deal Eli Lilly & Co. is dropping CVS Health Corp’s drug benefit plan for its employees after CVS stopped covering its blockbuster weight-loss drug in favor of a rival medication from Novo Nordisk A/S, according to people familiar with the matter. (https://www.bloomberg.com/) Wed. Nov 12, 2025 | |
| 11 (8) Why cutting drug prices is pushing Eli Lilly’s stock to all-time highs Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation. (https://www.marketwatch.com/) Tue. Nov 11, 2025 | |
| 12 (-5) Alcon Inc. Q3 Profit Decreases, Misses Estimates Alcon Inc. (ALC) reported earnings for third quarter that Decreased from the same period last year and missed the Street estimates. The company's earnings totaled $237 million, or $0. (https://www.rttnews.com/) Tue. Nov 11, 2025 | |
| 13 (5) Options Corner: Hims & Hers Health's Downturn Presents A Compelling Opportunity For Quants Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing for HIMS stock. (https://www.benzinga.com/) Tue. Nov 11, 2025 | |
| 14 (8) Why cutting drug prices is pushing Eli Lilly’s stock toward an all-time high Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation. (https://www.marketwatch.com/) Tue. Nov 11, 2025 | |
| 15 (7) Pfizer Inc. stock outperforms competitors on strong trading day Shares of Pfizer Inc. PFE rose 4.59% to $25.51 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.21% to 6,846.61 and the Dow Jones Industrial Average DJIA rising 1.18% to 47,927.96. The stock's rise snapped a two-day losing streak. (https://www.marketwatch.com/) Tue. Nov 11, 2025 | |
| 16 (7) Why Metsera is 'in better hands' with Pfizer than Novo Nordisk Pfizer (PFE) has beat out Novo Nordisk (NVO) in the bidding war for obesity medicine company Metsera (MTSR). BMO Capital Markets managing director of biopharma equity research, Evan Seigerman, discusses why he thinks the acquisition worked out in the best way for all parties. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. (https://finance.yahoo.com/) Tue. Nov 11, 2025 | |
| 17 (8) Dow rallies 500 points on gains in Nike, Merck shares Shares of Nike and Merck are trading higher Tuesday afternoon, leading the Dow Jones Industrial Average rally. The Dow Dow Jones Industrial Average was most recently trading 508 points (1.1%) higher, as shares of Nike Nike Inc. Cl B and Merck Merck & Co. Inc. have contributed to the index's intraday rally. (https://www.marketwatch.com/) Tue. Nov 11, 2025 | |
| 18 (-8) US Health Care Premium Spikes to Squeeze Main Street Businesses Then, she got notice last month that her health-care premiums will nearly quadruple next year. “It’s all of the things happening at once,” said Harrison, 58, one of 24 million Americans who rely on the Affordable Care Act marketplace for insurance. Small business owners like Harrison, along with their workers and people who are self-employed, make up nearly half of those enrolled in ACA plans, according to KFF, a nonpartisan health research foundation. (https://finance.yahoo.com/) Tue. Nov 11, 2025 | |
| 19 (0) Decoding UnitedHealth Group's Options Activity: What's the Big Picture? (https://www.benzinga.com/) Tue. Nov 11, 2025 | |
| 20 (-8) US Health Care Premium Spikes to Squeeze Main Street Businesses Gladys Harrison, owner of Big Mama’s Kitchen and Catering, was already struggling to cover rising food prices for ingredients at the Omaha restaurant that’s been in her family for two generations. Then, she got notice last month that her health-care premiums will nearly quadruple next year. (https://www.bloomberg.com/) Tue. Nov 11, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA